Regencell Bioscience Holdings Limited Filed Its Annual Report On Form 20-F For Fiscal Year Ended June 30, 2026
NEWS AND UPDATES Regencell Bioscience Holdings Limited Filed Its Annual Report On Form 20-F For Fiscal Year Ended June 30, 2026 HONG KONG, October 7, 2026 – Regencell Bioscience Holdings Limited (Nasdaq: RGC) (the “Company”), today announced that it filed its annual report on Form 20-F for the fiscal year ended June 30, 2026 with […]
RGC Foundation Donates to Salesian Youth Service, Benefiting Students Across 12 Schools
NEWS AND UPDATES RGC Foundation Donates to Salesian Youth Service, Benefiting Students Across 12 Schools The RGC Foundation remains steadfast in its commitment to uplifting underserved communities, providing essential grants and resources to support elders in financial distress as well as children facing ADHD and ASD. The driving force behind RGC’s mission stems from the […]
Spreading Warmth to 200 Families in Caged Homes
NEWS AND UPDATES Spreading Warmth to 200 Families in Caged Homes Regencell Foundation is honored to have partnered with the Society for Community Organization (SoCO) to extend practical aid, essential care packages, and warm smiles to 200 underserved families residing in caged homes and subdivided units across Hong Kong. Creating a tangible, positive impact in […]
Regencell Bioscience Holdings Limited Announces Registered Direct Offering of Ordinary Shares
NEWS AND UPDATES Regencell Bioscience Holdings Limited Announces Registered Direct Offering of Ordinary Shares HONG KONG, May 19, 2026 – Regencell Bioscience Holdings Limited (Nasdaq: RGC) (the “Company”), today announced that it has entered into a definitive agreement with investors for the purchase and sale of an aggregate of 985,222 of the Company’s ordinary share, […]
Regencell Bioscience Holdings Limited Announces At-the-Market Offering of Ordinary Shares
NEWS AND UPDATES Regencell Bioscience Holdings Limited Announces At-the-Market Offering of Ordinary Shares HONG KONG, March 30, 2026 – Regencell Bioscience Holdings Limited (Nasdaq: RGC) (the “Company”), today announced that it has filed a prospectus supplement with the U.S. Securities and Exchange Commission (“SEC”), under which it may offer and sell an aggregate of up […]
REGENCELL BIOSCIENCE HOLDINGS LIMITED FILED ITS ANNUAL REPORT ON FORM 20-F FOR FISCAL YEAR ENDED JUNE 30, 2025
NEWS AND UPDATES REGENCELL BIOSCIENCE HOLDINGS LIMITED FILED ITS ANNUAL REPORT ON FORM 20-F FOR FISCAL YEAR ENDED JUNE 30, 2025 HONG KONG, October 31, 2025 – Regencell Bioscience Holdings Limited (Nasdaq: RGC) (the “Company”), today announced that it filed its annual report on Form 20-F for the fiscal year ended June 30, 2025 with […]
Ms. Margaret Hoor Han Lo
Our People Company Directors Independent Director Ms. Margaret Hoor Han Lo Ms. Margaret Hoor Han Lo has been our independent director and member of audit committee, compensation committee and nominating and corporate governance committee since June 2025. Ms. Lo is a seasoned investor with over 30 years of extensive experience in the real estate investments. […]
Regencell Bioscience Holdings Limited Announces the Forward Stock Split is Effected
NEWS AND UPDATES Regencell Bioscience Holdings Limited Announces the Forward Stock Split is Effected HONG KONG, June 17, 2025 – Regencell Bioscience Holdings Limited (Nasdaq: RGC) (the “Company”), today announced that the Company has effected a 38-for-one forward stock split paid in the form of a stock bonus (the receipt of 37 additional shares for […]
